Filing Details
- Accession Number:
- 0001104659-10-063416
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-17 21:37:39
- Reporting Period:
- 2010-12-17
- Filing Date:
- 2010-12-17
- Accepted Time:
- 2010-12-17 21:37:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
881524 | Vivus Inc | VVUS | Pharmaceutical Preparations (2834) | 943136179 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1341526 | Wesley Day | 1172 Castro Street Mountain View CA 94040 | Vp, Clinical Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-12-17 | 60,000 | $3.26 | 87,400 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-12-17 | 66,600 | $9.54 | 20,800 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-12-17 | 60,000 | $0.00 | 60,000 | $3.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-11-14 | No | 4 | M | Direct |
Footnotes
- Includes 2,269 shares acquired on May 14, 2010 and 578 shares acquired on November 15, 2010 under the VIVUS, Inc. Employee Stock Purchase Plan.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $9.50 to $9.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.